Director Yeshwant Reports an $18 Million VERV Purchase

December 5, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Verve Therapeutics Inc $VERV director Krishna Yeshwant.

Yeshwant reported an $18 million purchase of VERV shares.

Graham Walmsley, director of Akero Therapeutics $AKRO, revealed the acquisition of 100,000 shares.

Here’s The Hot Corner, with data through December 5, 2023:

Over in Washington, Rep. Jonathan Jackson of Illinois reported a purchase worth between $15,000 and $50,000 in NVIDIA Corporation $NVDA.

In the options market, there was bullish flow in Darling Ingredients Inc $DAR, PagerDuty Inc $PD, Torrid Holdings Inc $CURV, and Samsara Inc $IOT.

Stay tuned. We’ll be back on Thursday with more insider activity.

Filed Under: